LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Search

Medtronic PLC

Abierto

Sector Salud

90 0.02

Resumen

Variación precio

24h

Actual

Mínimo

89.41

Máximo

90.22

Métricas clave

By Trading Economics

Ingresos

388M

1B

Ventas

-689M

7.9B

P/B

Media del Sector

25.47

103.001

BPA

1.23

Margen de beneficio

13.19

EBITDA

-561M

1.7B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+3.4 upside

Dividendos

By Dow Jones

Próximas Ganancias

19 nov 2024

Fecha Próximo Dividendo

11 oct 2024

Próxima Fecha de Ex Dividendo

27 sept 2024

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

117B

Apertura anterior

89.98

Cierre anterior

90

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

97 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Medtronic PLC Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

20 ago 2024, 11:19 UTC

Ganancias

Medtronic Nudges Outlook Higher After 1Q Results Rise

23 may 2024, 11:21 UTC

Ganancias

Medtronic 4Q Sales Top Forecasts, Issues FY25 Guidance

20 ago 2024, 11:12 UTC

Ganancias

Medtronic Posts Modest Beat-And-Raise Report For Fiscal First Quarter -- IBD

20 ago 2024, 10:57 UTC

Principales Noticias
Ganancias

Medtronic's Stock Gains After Profit And Sales Topped Forecasts, And The Full-Year Outlook Was Nudged Up -- MarketWatch

20 ago 2024, 10:47 UTC

Ganancias

Medtronic Sees FY25 Adj EPS $5.42-Adj EPS $5.50 >MDT

20 ago 2024, 10:47 UTC

Ganancias

Medtronic Sees FY25 Organic Revenue Growth of 4.5% to 5% >MDT

20 ago 2024, 10:45 UTC

Ganancias

Medtronic 1Q Sales $7.92B >MDT

20 ago 2024, 10:45 UTC

Ganancias

Medtronic 1Q Diabetes Rev $647M >MDT

20 ago 2024, 10:45 UTC

Ganancias

Medtronic 1Q Cardiovascular Portfolio Rev $3.01B >MDT

20 ago 2024, 10:45 UTC

Ganancias

Medtronic 1Q Adj EPS $1.23 >MDT

20 ago 2024, 10:45 UTC

Ganancias

Medtronic 1Q Medical Surgical Portfolio Rev $2B >MDT

20 ago 2024, 10:45 UTC

Ganancias

Medtronic 1Q Neuroscience Portfolio Rev $2.32B >MDT

20 ago 2024, 10:45 UTC

Ganancias

Medtronic 1Q EPS 80c >MDT

20 ago 2024, 10:45 UTC

Ganancias

Medtronic 1Q Net $1.04B >MDT

23 may 2024, 11:02 UTC

Ganancias

Medtronic's Stock Rises After Earnings Beat Expectations And The Dividend Was Raised -- MarketWatch

23 may 2024, 10:47 UTC

Ganancias

Medtronic Sees FY25 Organic Rev Growth of 4% to 5% >MDT

23 may 2024, 10:46 UTC

Ganancias

Medtronic Raises Dividend to 70c >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic Reports Full Year And Fourth Quarter Fiscal 2024 Financial Results; Announces Dividend Increase >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic 4Q Neuroscience Portfolio Rev $2.55B >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic 4Q Cardiovascular Portfolio Rev $3.13B >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic 4Q Medical Surgical Portfolio Rev $2.2B >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic 4Q Organic Revenue Up 5.4% >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic 4Q Diabetes Rev $660M >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic 4Q Net $654M >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic 4Q Adj EPS $1.46 >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic 4Q EPS 49c >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic Sees FY Adj EPS $5.40-Adj EPS $5.50 >MDT

23 may 2024, 10:45 UTC

Ganancias

Medtronic 4Q Sales $8.59B >MDT

20 may 2024, 07:40 UTC

Ganancias

Nvidia Earnings, Home Sales, Fed Minutes: What to Watch This Week -- WSJ

12 mar 2024, 10:41 UTC

Ganancias

Jamie Dimon Urges Fed Caution on Inflation and -2-

Comparación entre iguales

Cambio de precio

Medtronic PLC Esperado

Precio Objetivo

By TipRanks

3.4% repunte

Estimación a 12 meses

Media 93.06 USD  3.4%

Máximo 106 USD

Mínimo 82 USD

De acuerdo con 21 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Medtronic PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

21 ratings

8

Comprar

11

Mantener

2

Vender

Puntuación técnica

By Trading Central

89.355 / 90.535Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

97 / 365 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Medtronic PLC

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.